Viacom, Inc. (NASDAQ:VIAB) reported on Monday that hired Tom Gorke to the recently created position of executive VP, Sales and Business Development for Viacom Media Networks and BET Networks. In his role, Gorke will lead sales as well as new business efforts for all linear and digital distribution alliances across BET, CMT, Comedy Central, MTV, Nickelodeon, Logo, Spike TV, TV Land and VH1, as well as Viacom’s joint venture EPIX. Whereas, shares of Viacom, Inc. (NASDAQ:VIAB) traded up of 1.74% to finished at USD68.24 with market capitalization of 3.67 million. Separately, a research note to investors, 13 analysts rates its stocks at “Hold,” 7 analysts rate it at “strong buy” and 9 rate it a “Buy.”
Computer Sciences Corporation (NYSE:CSC) released that its third quarter earnings of $1.18 per share, excluding non-recurring items. The firm $0.06 improved than the Capital IQ Consensus Estimate of $1.12. The firm revenues dropped 8.7 percent year per year to $2.95B as compared to the $3.18B consensus. Computer Sciences Corporation (NYSE:CSC) stock decrease of -0.28% to closed at $64.84with the total traded volume of 1.73 million shares. The consensus average revenue estimates are $3.18B for latest quarter, at the same time as 13 experts predict $3.29B revenues for the next three months of 2014.
A provider of diagnostic information services, Quest Diagnostics Inc (NYSE:DGX) and Myriad Genetics Inc. (MYGN) have signed a contract that ends their BRCA gene-patent litigation. As division of the contract, Quest Diagnostics as well as Myriad Genetics and its co-parties in the litigation, the University of Utah Research Foundation, the Trustees of the University of Pennsylvania, HSC Research and Development Limited Partnership, and Endorecherche, Inc. dismiss their lawsuits, claims, counterclaims and disputes related to Myriad’s patent claims on BRCA1 and BRCA2 in the litigation. Quest Diagnostics Inc (NYSE:DGX) saw as a loser stock in last session, fell -0.79% to finished at $69.09 with the overall traded volume of 1.71million shares. The street professionals’ recommendation trends reflect as, stock on “Buy” rating by 4 analysts, while 17 analysts rate its shares as a “hold” security.
Manitowoc Company Inc (NYSE:MTW) declared that it has signed contract with Carl C. Icahn pursuant to which the Manitowoc Board has committed to sure corporate governance provisions for Manitowoc as well as for the Foodservice entity. The firm noted that the contract with Carl Icahn also provides for, mid other things, certain customary “standstill” restrictions, and Manitowoc has committed not to reduce its shareholder rights plan’s trigger below 20 percent for the duration of the standstill contract. Manitowoc Company Inc (NYSE:MTW) after opening at $20.52 hit its day high price of $21.18 moreover rose 2.24% to closed at $21.00. The consensus average revenue estimates are $834.85M for latest quarter, at the same time as 15 experts predict $986.53M revenues for the next three months of 2014.
